- Home
- OPI vs PEPG Comparison
OPI vs PEPG Comparison
Compare OPI & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPI
- PEPG
- Stock Information
- Founded
- OPI 2009
- PEPG 2018
- Country
- OPI United States
- PEPG United States
- Employees
- OPI N/A
- PEPG N/A
- Industry
- OPI Real Estate Investment Trusts
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- OPI Real Estate
- PEPG Health Care
- Exchange
- OPI Nasdaq
- PEPG Nasdaq
- Market Cap
- OPI 105.1M
- PEPG 118.3M
- IPO Year
- OPI 2009
- PEPG 2022
- Fundamental
- Price
- OPI $0.92
- PEPG $2.08
- Analyst Decision
- OPI Buy
- PEPG Buy
- Analyst Count
- OPI 2
- PEPG 3
- Target Price
- OPI $4.30
- PEPG $14.67
- AVG Volume (30 Days)
- OPI 830.8K
- PEPG 158.0K
- Earning Date
- OPI 02-13-2025
- PEPG 03-05-2025
- Dividend Yield
- OPI 4.48%
- PEPG N/A
- EPS Growth
- OPI N/A
- PEPG N/A
- EPS
- OPI N/A
- PEPG N/A
- Revenue
- OPI $517,514,000.00
- PEPG N/A
- Revenue This Year
- OPI N/A
- PEPG N/A
- Revenue Next Year
- OPI N/A
- PEPG N/A
- P/E Ratio
- OPI N/A
- PEPG N/A
- Revenue Growth
- OPI N/A
- PEPG N/A
- 52 Week Low
- OPI $0.86
- PEPG $2.09
- 52 Week High
- OPI $4.06
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- OPI 35.25
- PEPG 18.60
- Support Level
- OPI $0.87
- PEPG $3.69
- Resistance Level
- OPI $0.94
- PEPG $4.48
- Average True Range (ATR)
- OPI 0.06
- PEPG 0.27
- MACD
- OPI 0.01
- PEPG -0.09
- Stochastic Oscillator
- OPI 32.61
- PEPG 0.25
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its largest tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.